(CX) Cemex SAB de CV - Ratings and Ratios

Exchange: NYSE • Country: Mexico • Currency: USD • Type: Common Stock • ISIN: US1512908898

Cement, Concrete, Aggregates, Services

Stock: Construction Materials
Age 26.4y

MCap 17,918m
Avg Vol 5.03M (59.5M USD)

Beta 0.812
Volatility 32.38%

EPS (Earnings per Share)

EPS CAGR: -8.81%
EPS Trend: 20.8%

Last SUE: -0.75
Qual. Beats: 0

Revenue

Rev. CAGR: 4.71%
Rev. Trend: 36.3%

Last SUE: 0.04
Qual. Beats: 0

Dividends

Dividend Yield	1.11%
Yield on Cost 5y	1.45%
Yield CAGR 5y	39.68%
Payout Consistency	38.4%
Payout Ratio	9.4%

Risk via 5d forecast
Volatility	32.4%
Value at Risk 5%th	51.8%
Relative Tail Risk	-2.75%

Reward TTM
Sharpe Ratio	2.51
Alpha	129.90
CAGR/Max DD	0.85

Character TTM
Hurst Exponent	0.471
Beta	0.812
Beta Downside	1.082

Drawdowns 3y
Max DD	44.37%
Mean DD	16.45%
Median DD	13.08%

Description: CX Cemex SAB de CV January 02, 2026

CEMEX, S.A.B. de C.V. (NYSE: CX) is a Mexico-based, globally diversified builder of construction materials, producing cement, ready-mix concrete, aggregates, and a suite of urban-development solutions. Its product portfolio spans gray and white Portland cement, specialty blends for oil-well applications, a wide array of concrete mixes (including rapid-setting, fiber-reinforced, and antibacterial types), and recycled-content aggregates, complemented by logistics, engineering, waste-management, and prefabricated construction services.

Key quantitative points (2023 FY): total revenue ≈ $15.5 bn, EBITDA margin ≈ 12 %, and a net debt-to-EBITDA ratio of roughly 3.1×, reflecting a capital-intensive balance sheet but steady cash generation. The business is heavily influenced by macro-drivers such as global infrastructure spending (projected ~4 % CAGR through 2028), residential construction cycles in the United States and Europe, and the industry’s transition toward lower-carbon clinker substitutes and alternative fuels, which can affect both cost structure and regulatory risk.

For a deeper quantitative breakdown, you might explore ValueRay’s analyst toolkit to see how these fundamentals compare across peers.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income: 1.36b TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.31 > 1.0
NWC/Revenue: -3.60% < 20% (prev -0.66%; Δ -2.94% < -1%)
CFO/TA 0.07 > 3% & CFO 2.09b > Net Income 1.36b
Net Debt (1.88b) to EBITDA (2.04b): 0.92 < 3
Current Ratio: 0.91 > 1.5 & < 3
Outstanding Shares: last quarter (1.47b) vs 12m ago -3.11% < -2%
Gross Margin: 32.05% > 18% (prev 0.33%; Δ 3171 % > 0.5%)
Asset Turnover: 55.55% > 50% (prev 58.64%; Δ -3.09% > 0%)
Interest Coverage Ratio: 3.17 > 6 (EBITDA TTM 2.04b / Interest Expense TTM 517.0m)

Altman Z'' (< 1.1 .. > 2.6) 1.39

A: -0.02 (Total Current Assets 5.96b - Total Current Liabilities 6.53b) / Total Assets 29.01b
B: 0.22 (Retained Earnings 6.43b / Total Assets 29.01b)
C: 0.06 (EBIT TTM 1.64b / Avg Total Assets 28.50b)
D: 0.39 (Book Value of Equity 5.91b / Total Liabilities 15.09b)
Altman-Z'' Score: 1.39 = BB

ValueRay F-Score (Strict, 0-100) 64.98

1. Piotroski: 7.50pt
2. FCF Yield: 5.06%
3. FCF Margin: 6.33%
4. Debt/Equity: 0.23
5. Debt/Ebitda: 0.92
6. ROIC - WACC: -0.49%
7. RoE: 10.46%
8. Revenue Trend: 36.26%
9. EPS Trend: 20.80%

What is the price of CX shares?

As of January 22, 2026, the stock is trading at USD 12.92 with a total of 6,443,301 shares traded.
Over the past week, the price has changed by +2.78%, over one month by +9.68%, over three months by +41.32% and over the past year by +137.06%.

Is CX a buy, sell or hold?

Cemex SAB de CV has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold CX.

Strong Buy: 3
Buy: 6
Hold: 4
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	11.7	-9.6%
Analysts Target Price	11.7	-9.6%
ValueRay Target Price	15.4	19%

CX Fundamental Data Overview January 17, 2026

P/E Trailing = 13.5714
P/E Forward = 15.528
P/S = 1.129
P/B = 1.3172
P/EG = 0.1074
Revenue TTM = 15.83b USD
EBIT TTM = 1.64b USD
EBITDA TTM = 2.04b USD
Long Term Debt = 5.14b USD (from longTermDebt, last quarter)
Short Term Debt = 289.0m USD (from shortTermDebt, last quarter)
Debt = 3.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.88b USD (from netDebt column, last quarter)
Enterprise Value = 19.80b USD (17.92b + Debt 3.08b - CCE 1.20b)
Interest Coverage Ratio = 3.17 (Ebit TTM 1.64b / Interest Expense TTM 517.0m)
EV/FCF = 19.76x (Enterprise Value 19.80b / FCF TTM 1.00b)
FCF Yield = 5.06% (FCF TTM 1.00b / Enterprise Value 19.80b)
FCF Margin = 6.33% (FCF TTM 1.00b / Revenue TTM 15.83b)
Net Margin = 8.62% (Net Income TTM 1.36b / Revenue TTM 15.83b)
Gross Margin = 32.05% ((Revenue TTM 15.83b - Cost of Revenue TTM 10.76b) / Revenue TTM)
Gross Margin QoQ = 33.58% (prev 33.96%)
Tobins Q-Ratio = 0.68 (Enterprise Value 19.80b / Total Assets 29.01b)
Interest Expense / Debt = 3.58% (Interest Expense 110.3m / Debt 3.08b)
Taxrate = 33.55% (121.0m / 360.8m)
NOPAT = 1.09b (EBIT 1.64b * (1 - 33.55%))
Current Ratio = 0.91 (Total Current Assets 5.96b / Total Current Liabilities 6.53b)
Debt / Equity = 0.23 (Debt 3.08b / totalStockholderEquity, last quarter 13.60b)
Debt / EBITDA = 0.92 (Net Debt 1.88b / EBITDA 2.04b)
Debt / FCF = 1.88 (Net Debt 1.88b / FCF TTM 1.00b)
Total Stockholder Equity = 13.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.79% (Net Income 1.36b / Total Assets 29.01b)
RoE = 10.46% (Net Income TTM 1.36b / Total Stockholder Equity 13.05b)
RoCE = 9.01% (EBIT 1.64b / Capital Employed (Equity 13.05b + L.T.Debt 5.14b))
RoIC = 7.46% (NOPAT 1.09b / Invested Capital 14.60b)
WACC = 7.95% (E(17.92b)/V(21.00b) * Re(8.91%) + D(3.08b)/V(21.00b) * Rd(3.58%) * (1-Tc(0.34)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.75%
[DCF Debug] Terminal Value 77.82% ; FCFF base≈841.0m ; Y1≈815.7m ; Y5≈812.6m
Fair Price DCF = 8.70 (EV 14.51b - Net Debt 1.88b = Equity 12.62b / Shares 1.45b; r=7.95% [WACC]; 5y FCF grow -4.15% → 2.90% )
EPS Correlation: 20.80 | EPS CAGR: -8.81% | SUE: -0.75 | # QB: 0
Revenue Correlation: 36.26 | Revenue CAGR: 4.71% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=0.81 | Chg30d=+0.013 | Revisions Net=+0 | Growth EPS=+2.3% | Growth Revenue=+5.2%

Additional Sources for CX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle